Hepatitis C virus transmission cluster among injection drug users in Pakistan

PLoS One. 2022 Jul 15;17(7):e0270910. doi: 10.1371/journal.pone.0270910. eCollection 2022.

Abstract

Hepatitis C virus (HCV) infections are public health problem across the globe, particularly in developing countries. Pakistan has the second highest prevalence of HCV infection worldwide. Limited data exist from Pakistan about persons who inject drugs (PWID) and are at significant risk of exposure to HCV infection and transmission. Serum specimens (n = 110) collected from PWID residing in four provinces were tested for molecular markers of HCV infection. Next generation sequencing (NGS) of the hypervariable region (HVR1) of HCV and Global Hepatitis Outbreak and Surveillance Technology (GHOST) were used to determine HCV genotype, genetic heterogeneity, and construct transmission networks. Among tested specimens, 47.3% were found anti-HCV positive and 34.6% were HCV RNA-positive and belonged to four genotypes, with 3a most prevalent followed by 1a, 1b and 4a. Variants sampled from five cases formed phylogenetic cluster and a transmission network. One case harbored infection with two different genotypes. High prevalence of infections and presence of various genotypes indicate frequent introduction and transmission of HCV among PWID in Pakistan. Identification of a transmission cluster across three provinces, involving 20% of all cases, suggests the existence of a countrywide transmission network among PWIDs. Understanding the structure of this network should assist in devising effective public health strategies to eliminate HCV infection in Pakistan.

MeSH terms

  • Drug Users*
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C*
  • Humans
  • Pakistan / epidemiology
  • Phylogeny
  • Prevalence
  • Substance Abuse, Intravenous* / epidemiology

Grants and funding

The author(s) received no specific funding for this work.